|
Volumn 45, Issue 10, 2001, Pages 2710-2715
|
Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
INDINAVIR;
PROTEINASE INHIBITOR;
RITONAVIR;
VIRUS RNA;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
FAT INTAKE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VIRUS INFECTION;
ADOLESCENT;
ADULT;
AREA UNDER CURVE;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
DRUG TOLERANCE;
FEMALE;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
MALE;
MIDDLE AGED;
RITONAVIR;
|
EID: 0034801355
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.45.10.2710-2715.2001 Document Type: Article |
Times cited : (56)
|
References (12)
|